Your browser doesn't support javascript.
loading
Pharmacological and Behavioral Strategies to Improve Vision in Acquired Pendular Nystagmus.
Kerkeni, Hassen; Brügger, Dominik; Mantokoudis, Georgios; Abegg, Mathias; Zee, David S.
Afiliação
  • Kerkeni H; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Brügger D; Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Mantokoudis G; Department of Otorhinolaryngology, Head and Neck Surgery, lnselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Abegg M; Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Zee DS; Department of Neurology, Ophthalmology, Otolaryngology-Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, MD, USA.
Am J Case Rep ; 23: e935148, 2022 Jul 03.
Article em En | MEDLINE | ID: mdl-35780294
BACKGROUND Acquired pendular nystagmus (APN) is a back and forth, oscillatory eye movement in which the 2 oppositely directed slow phases have similar waveforms. APN occurs commonly in multiple sclerosis and causes a disabling oscillopsia that impairs vision. Previous studies have proven that symptomatic therapy with gabapentin or memantine can reduce the nystagmus amplitude or frequency. However, the effect of these medications on visual acuity (VA) is less known and to our knowledge the impact of non-pharmacological strategies such as blinking on VA has not been reported. This is a single observational study without controls (Class IV) and is meant to suggest a future strategy for study of vision in patients with disabling nystagmus and impaired vision. CASE REPORT A 49-year-old woman with primary progressive multiple sclerosis with spastic paraparesis and a history of optic atrophy presented with asymmetrical binocular APN and bothersome oscillopsia. We found that in the eye with greater APN her visual acuity improved by 1 line (from 0.063 to 0.08 decimals) immediately after blinking. During treatment with memantine, her VA without blinking increased by 2 lines, from 0.063 to 0.12, but improved even more (from 0.12 to 0.16) after blinking. In the contralateral eye with a barely visible nystagmus, VA was reduced by 1 line briefly (~500 ms) after blinking. CONCLUSIONS In a patient with APN, blinking transiently improved vision. The combination of pharmacological treatment with memantine and the blinking strategy may induce better VA and less oscillopsia than either alone.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Memantina / Nistagmo Patológico Tipo de estudo: Etiology_studies / Observational_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Memantina / Nistagmo Patológico Tipo de estudo: Etiology_studies / Observational_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article